CJC-1295 (With DAC)

CJC-1295 (With DAC) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied in research environments for its ability to stimulate and prolong growth hormone signaling through pituitary receptor activation. In simple terms, it is used in laboratory research to examine how extended GHRH activity influences natural growth hormone release patterns and downstream endocrine responses in controlled biological models.

From a technical standpoint, CJC-1295 is a 30-amino-acid modified GHRH analog engineered with a Drug Affinity Complex (DAC) attachment. This modification allows the peptide to bind reversibly to serum albumin, significantly extending its half-life and duration of action in research models. As a result, CJC-1295 (With DAC) produces sustained stimulation of the growth hormone axis compared to short-acting GHRH analogs, making it useful for studying prolonged endocrine signaling dynamics.

In laboratory and clinical research settings, CJC-1295 (With DAC) is commonly evaluated within the somatotropic axis, including growth hormone secretion, IGF-1 signaling pathways, metabolic regulation mechanisms, and feedback interactions within the endocrine system. Its long-acting profile allows researchers to observe steady-state hormonal changes over extended periods in preclinical models.

CJC-1295 (With DAC) is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

• Growth hormone-releasing hormone (GHRH) receptor activation
• Long-acting pituitary hormone stimulation studies
• Somatotropic axis and endocrine feedback regulation
• IGF-1 signaling pathway research
• Albumin-binding peptide pharmacokinetics (DAC technology)

Chemical Information

• Compound Name: CJC-1295
• Type: Synthetic GHRH analog peptide
• Variants: With DAC / Without DAC
• Mechanism: Growth hormone-releasing hormone receptor agonist
• Research Focus: Endocrine and metabolic signaling pathways
• Half-life: Extended in DAC-modified version (albumin binding)

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.